Lifecore Biomedical Statistics
NASDAQ: LFCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.43-0.01 (-0.16%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Lifecore Biomedical by the numbers
Lifecore Biomedical has a market capitalization of $243.7 million based on 37.91M shares outstanding. With trailing EPS of $-1.27, Lifecore Biomedical is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.0% above its 50-day average and 14.2% above its 200-day average.
Average daily trading volume is 294.61K shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LFCR valuation vs. peer median
| Metric | LFCR | Peer median | Difference |
|---|---|---|---|
| Market cap | $243.73M | $244.13M | -0% |
| Avg. volume | 294.61K | 717.43K | -59% |
Peer median across 8 companies: IMRX, ZNTL, QTTB, VCRE, UPB, PYXS, SIGA, AMRN.
Valuation
- Market cap
- $243.73M
- EPS (TTM)
- $-1.27
- Shares outstanding
- 37.91M
Price and trading
- Previous close
- 6.44
- Open
- 6.43
- Day range
- 6.42 – 6.46
- 52-week range
- 3.63 – 8.98
- 52-week change
- -6.40%
- Beta
- —
- Volume
- 492.06K
- Average volume
- 294.61K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 5, 2026
Additional statistics
- Market Cap
- 243.73M
- Forward Pe
- -8.24
- Eps
- -1.27
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.98
- Week52 Low
- 3.63
- Avg Volume
- 294.61K
- Shares Outstanding
- 37.91M
- Ma50
- 4.84
- Ma200
- 5.63
- Earnings Date
- Aug 5, 2026
- Pct From52w High
- -28.40%
- Pct From52w Low
- 77.13%